Session: VL1
Valvular Heart Disease

Julie Phillippi (University of Pittsburgh), George Fercana (University of Pittsburgh), Jennifer Hill (University of Pittsburgh), Marie Billaud (University of Pittsburgh), Tara Richards (University of Pittsburgh), Stephen Badylak (University of Pittsburgh), Thomas Gleason (University of Pittsburgh)

Nicolas Marinval (Laboratory for Vascular Translational Science, Inserm U1148, Hôpital Xavier Bichat, Paris, France / Institut Galilée, University Paris 13, Sorbonne Paris Cité, France), Malgorzata Morenc (Bioengineering Laboratory, Heart prosthesis institute, Zabrze, Poland / University of Silesia, Katowice, Poland), Nathalie Charnaux (Laboratory for Vascular Translational Science, Inserm U1148, Hôpital Xavier Bichat, Paris / Institut Galilée, University Paris 13, Sorbonne Paris Cité / Laboratory of biochemistry, Hôpital Jean Verdier, Bondy, France.), Piotr Wilczek (Bioengineering Laboratory, Heart prosthesis institute, Zabrze, Poland / University of Silesia, Katowice, Poland), Hanna Hlawaty (Laboratory for Vascular Translational Science, Inserm U1148, Hôpital Xavier Bichat, Paris, France / Institut Galilée, University Paris 13, Sorbonne Paris Cité)